(Q45755649)

15 December 2017

title

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group (English)

1 reference

15 December 2017

1 reference

1 reference

1 reference

Allen MI

1

1 reference

15 December 2017

Deslauriers M

2

1 reference

15 December 2017

Andrews CW

3

1 reference

15 December 2017

Tipples GA

4

1 reference

15 December 2017

Walters KA

5

1 reference

15 December 2017

Tyrrell DL

6

1 reference

15 December 2017

Brown N

7

1 reference

15 December 2017

Condreay LD

8

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

15 December 2017

published in

Hepatology

1 reference

15 December 2017

volume

27

1 reference

15 December 2017

issue

6

1 reference

15 December 2017

page(s)

1670-1677

1 reference

15 December 2017

Hepatitis B: global importance and need for control

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270628

7 January 2021

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270628

7 January 2021

Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-beta-L-2',3'-dideoxy-3'-thiacytidine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270628

7 January 2021

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270628

7 January 2021

Evaluation of safety and efficacy of 3TC (lamivudine) in patients with asymptomatic or mildly symptomatic human immunodeficiency virus infection: a phase I/II study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270628

7 January 2021

Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC).

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270628

7 January 2021

Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270628

7 January 2021

Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270628

7 January 2021

Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270628

7 January 2021

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270628

7 January 2021

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270628

7 January 2021

Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270628

7 January 2021

Mutations in the epsilon sequences of human hepatitis B virus affect both RNA encapsidation and reverse transcription

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270628

7 January 2021

Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270628

7 January 2021

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270628

7 January 2021

High-capacity in vitro assessment of anti-hepatitis B virus compound selectivity by a virion-specific polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270628

7 January 2021

The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270628

7 January 2021

Computer analysis of retroviral pol genes: assignment of enzymatic functions to specific sequences and homologies with nonviral enzymes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270628

7 January 2021

Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270628

7 January 2021

Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270628

7 January 2021

Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270628

7 January 2021

Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270628

7 January 2021

Identifiers

DOI

10.1002/HEP.510270628

1 reference

15 December 2017

PubMed ID

9620341

1 reference

15 December 2017